Cousin, F.; Louis, T.; Dheur, S.; Aboubakar, F.; Ghaye, B.; Occhipinti, M.; Vos, W.; Bottari, F.; Paulus, A.; Sibille, A.;
et al. Radiomics and Delta-Radiomics Signatures to Predict Response and Survival in Patients with Non-Small-Cell Lung Cancer Treated with Immune Checkpoint Inhibitors. Cancers 2023, 15, 1968.
https://doi.org/10.3390/cancers15071968
AMA Style
Cousin F, Louis T, Dheur S, Aboubakar F, Ghaye B, Occhipinti M, Vos W, Bottari F, Paulus A, Sibille A,
et al. Radiomics and Delta-Radiomics Signatures to Predict Response and Survival in Patients with Non-Small-Cell Lung Cancer Treated with Immune Checkpoint Inhibitors. Cancers. 2023; 15(7):1968.
https://doi.org/10.3390/cancers15071968
Chicago/Turabian Style
Cousin, François, Thomas Louis, Sophie Dheur, Frank Aboubakar, Benoit Ghaye, Mariaelena Occhipinti, Wim Vos, Fabio Bottari, Astrid Paulus, Anne Sibille,
and et al. 2023. "Radiomics and Delta-Radiomics Signatures to Predict Response and Survival in Patients with Non-Small-Cell Lung Cancer Treated with Immune Checkpoint Inhibitors" Cancers 15, no. 7: 1968.
https://doi.org/10.3390/cancers15071968
APA Style
Cousin, F., Louis, T., Dheur, S., Aboubakar, F., Ghaye, B., Occhipinti, M., Vos, W., Bottari, F., Paulus, A., Sibille, A., Vaillant, F., Duysinx, B., Guiot, J., & Hustinx, R.
(2023). Radiomics and Delta-Radiomics Signatures to Predict Response and Survival in Patients with Non-Small-Cell Lung Cancer Treated with Immune Checkpoint Inhibitors. Cancers, 15(7), 1968.
https://doi.org/10.3390/cancers15071968
